Filing Details
- Accession Number:
- 0001053369-14-000003
- Form Type:
- 4/A
- Zero Holdings:
- No
- Publication Time:
- 2014-01-06 17:28:50
- Reporting Period:
- 2013-11-15
- Filing Date:
- 2014-01-06
- Accepted Time:
- 2014-01-06 17:28:50
- Original Submission Date:
- 2013-11-14
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1053369 | Elite Pharmaceuticals Inc | ELTP | Pharmaceutical Preparations (2834) | 223542636 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1465825 | G Ashok Nigalaye | C/O Epic Pharma, Llc 227-15 North Conduit Avenue Laurelton NY 11413 | Chief Scientific Officer | Yes | Yes | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2013-11-15 | 253,050 | $0.12 | 21,885,148 | No | 4 | S | Indirect | By Epic Investments, LLC |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Indirect | By Epic Investments, LLC |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 12,055,183 | Direct |
Footnotes
- Ashok G. Nigalaye is an equity owner and executive officer of each of Epic Investments, LLC ("EI") and Epic Pharma, LLC ("EP"), which is a 10% owner of the issuer, and also serves as a director of the issuer.
- Represents the reporting person's pro-rata ownership of the issuer owned by EP. The reporting person disclaims beneficial ownership of such securities except, to the extent of its pecuniary interest in EI.
- This amended Form 4 is filed to decrease the total number of shares sold by 65,000. The original filing reported 318,050 shares sold when the actual number of shares sold was 253,050
- All subsequent filings up through today's date hereof decrease the total number of shares in column 5 by 65,000 shares.
Billionaire Hedge Funds
